CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, Human Resources sold 2,681 shares at $300.00 ($804,300)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 144 Insider Sale of Securities
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change
- 4 Planned sale Head of Development sold 91 shares at $277.11 ($25,217)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 116 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Open-market sale Head of Development sold 568 shares at $270.06 ($153,394)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Other events
- 4 Shares withheld for taxes Head of Development gave up 687 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Development gave up 151 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 233 shares (to pay taxes)
Page 15 of 137 · 2,721 filings